SEATTLE--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that SGN-35 will be highlighted in an oral presentation during a plenary session on Saturday, June 7, 2008 at the International Conference on Malignant Lymphoma (ICML) being held in Lugano, Switzerland.
